evidencegaps
Findings

What do systematic reviews say?

Refine by population, intervention, comparison or outcome
More filters
Evidence found and GRADE certainty

344 questions · 378 findings · 34 reviews · Headline outcomes only

Sort:Best matchNewestHighest certaintyDownload CSV
No studies found 80 · 21.2%GRADE not reported 26 · 6.9%Very low 55 · 14.6%Low 106 · 28%Moderate 93 · 24.6%High 18 · 4.8%

Pulse vs continuous dexamethasone therapy

Death or bronchopulmonary dysplasia at 36 weeks PMA · preterm infants at risk for bronchopulmonary dysplasia

Pulse may leads to higher death or bronchopulmonary dysplasia at 36 weeks' PMA compared with continuous dexamethasone therapy (low certainty).

1 finding from 1 review

Pulmonary artery perfusion with blood vs no perfusion during cardiopulmonary bypass

Number of participants with pulmonary events within longest · adult surgical patients with the need for cardiopulmonary bypass‐dependent heart surgery

The review found no eligible studies for this question.

1 finding from 1 review

Pulse vs continuous dexamethasone therapy

Death or abnormal neurodevelopmental outcome (various definitions) · preterm infants at risk for bronchopulmonary dysplasia

It is very uncertain whether pulse changes death or abnormal neurodevelopmental outcome (various definitions) compared with continuous dexamethasone therapy (very low certainty).

1 finding from 1 review

PUL vs TURP

Retreatment

It is very uncertain whether PUL changes retreatment compared with TURP (very low certainty).

2 findings from 1 review

PUL vs TURP

Major adverse events

It is very uncertain whether PUL changes major adverse events compared with TURP (very low certainty).

2 findings from 1 review